Molecular modeling of receptors for adenosine and nucleotide (P2) receptors
with docked ligand, based on mutagenesis, was carried out. Adenosine 3',5'
-bisphosphate derivatives act as selective P2Y(1) antagonists/partial agoni
sts. The ribose moiety was replaced with carbocyclics, smaller and larger r
ings, conformationally constrained rings, and acyclics, producing compounds
that retained receptor affinity. Conformational constraints were built int
o the ribose rings of nucleoside and nucleotide ligands using the methanoca
rba approach, i.e. fused cyclopropane and cyclopentane rings in place of ri
bose, suggesting a preference for the Northern (N) conformation among ligan
ds for P2Y(1) and A(1) and A(3)ARs.